APA (7th ed.) Citation

M, M., DN, J., DS, L., PA, R., A, K., G, N., . . . TA, S. (2004). Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: A population-based cohort study. Lancet, 363(9423), 1751. https://doi.org/10.1016/s0140-6736(04)16299-5

Chicago Style (17th ed.) Citation

M, Mamdani, Juurlink DN, Lee DS, Rochon PA, Kopp A, Naglie G, Austin PC, Laupacis A, and Stukel TA. "Cyclo-oxygenase-2 Inhibitors Versus Non-selective Non-steroidal Anti-inflammatory Drugs and Congestive Heart Failure Outcomes in Elderly Patients: A Population-based Cohort Study." Lancet 363, no. 9423 (2004): 1751. https://doi.org/10.1016/s0140-6736(04)16299-5.

MLA (9th ed.) Citation

M, Mamdani, et al. "Cyclo-oxygenase-2 Inhibitors Versus Non-selective Non-steroidal Anti-inflammatory Drugs and Congestive Heart Failure Outcomes in Elderly Patients: A Population-based Cohort Study." Lancet, vol. 363, no. 9423, 2004, p. 1751, https://doi.org/10.1016/s0140-6736(04)16299-5.